New pill aims to shrink hard-to-treat cancers
NCT ID NCT06545942
First seen Oct 31, 2025 · Last updated Apr 29, 2026 · Updated 25 times
Summary
This early-stage study tests an experimental drug called MOMA-313, taken as a pill, either alone or with another drug (olaparib), in people with advanced solid tumors that have a specific DNA repair problem. The main goal is to check safety and find the best dose. About 220 adults with certain cancers (like prostate, pancreas, breast, or ovarian) that have not responded to standard treatments may join.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigative Site #101
La Jolla, California, 92093, United States
-
Investigative Site #102
Nashville, Tennessee, 37203, United States
-
Investigative Site #103
New York, New York, 10016, United States
-
Investigative Site #104
Lake Mary, Florida, 32746, United States
-
Investigative Site #105
San Antonio, Texas, 78229, United States
-
Investigative Site #106
New York, New York, 10065, United States
-
Investigative Site #107
Myrtle Beach, South Carolina, 29572, United States
-
Investigative Site #108
Goodyear, Arizona, 85338, United States
-
Investigative Site #109
Philadelphia, Pennsylvania, 19104, United States
-
Investigative Site #110
St Louis, Missouri, 63110, United States
-
Investigative Site #111
San Francisco, California, 94143, United States
-
Investigative Site #112
Fairfax, Virginia, 22031, United States
-
Investigative Site #113
London, United Kingdom
-
Investigative Site #114
Barcelona, Spain
-
Investigative Site #115
Madrid, Spain
-
Investigative Site #116
Barcelona, Spain
-
Investigative Site #117
Manchester, United Kingdom
-
Investigative Site #118
Newcastle upon Tyne, United Kingdom
Conditions
Explore the condition pages connected to this study.